Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation

BACKGROUND: Activation of the immune system is suggested to prevent transplant tolerance and to promote the development of bronchiolitis obliterans syndrome (BOS). The innate immune system is activated by the interaction of pathogen-associated molecular patterns of microorganisms with Toll-like receptors (TLRs). Activation of innate immunity via TLRs was shown to be a barrier to the induction of transplantation tolerance after lung transplantation. We hypothesized that polymorphisms in 10 genes coding for TLR1 to TLR1 0 might contribute to an altered immune response and the subsequent development of BOS. METHODS: DNA was collected from 110 lung transplant recipients. Twenty patients developed BOS. The control group comprised 422 individuals. Sixty-four single-nucleotide polymorphisms (SNPs) in 10 genes coding for TLR10 to TLR10 were genotyped. RESULTS: The genotype distribution of TLR2 (rs1898830 and rs7656411), TLR4 (rs1927911) and TLR9 (rs352162 and rs187084) was significantly different between BOSpos patients and BOSneg patients and controls. The BOSpos group had significantly more patients with 3 or 4 of these risk alleles compared with the BOSneg and control groups. CONCLUSIONS: Polymorphisms in TLR2, TLR4 and TLR9 that recognize bacterial and viral pathogens are associated with BOS after lung transplantation. J Heart Lung Transplant 2010;29:665-71 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.